Global biomedical company that
leads innovative medical products
A Global Company Developing Innovative Medical Products
Strategic partnership with
Global biomedical company
Strategic Partnerships with Global Medical Device Companies
Global biomedical company that
leads innovative medical products
A Global Company Developing Innovative Medical Products
Strategic partnership with
Global biomedical company
Strategic Partnerships with Global Medical Device Companies
In cooperation with Medtronic,
the world’s largest medical device company.
European CE certification obtained
US FDA approval expected
A global-level quality
management system established
Endoscopic hemostatic system for Gastrointestinal bleeding:
High immediate hemostasis rate, low rebleeding rate, minimal powder
scattering and catheter clogging
Nexsphere™ a resorbable microsphere that exhibits embolic performance in a variety
of indications with uniform spherical particles, high elasticity and strong cohesion.
[Nexpowder] Hemostatic efficacy and safety of the hemostatic powder UI-EWD in patients
Jul 13th,2022
[Nexsphere] Short-term Results of Transcatheter Arterial Embolization for Chronic Medial Epicondylitis Refractory to Conservative Treatment
Nov 2th,2021
[Nexpowder] Efficacy of a novel hemostatic adhesive powder in patients with upper gastrointestinal tumor bleeding
Nov 2th,2021
[Nexpowder] Hemostatic materials in non-variceal upper gastrointestinal hemorrhage
Nov 2th,2021